Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

043. Clinical Trials: Thursday, 12:15 - 1:30 p.m.

Poster Session: Clinical Trials

(383) Pharmacokinetics and Safety in Healthy Adults of RSM01, a Novel RSV Monoclonal Antibody, and Population PK Modeling to Support Pediatric Development

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Co-Author(s)

  • ML

    Micha Levi, PhD

    Bill & Melinda Gates Medical Research Institute
    Cambridge, Massachusetts, United States

  • SW

    Shayne Watson, MSc

    Bill & Melinda Gates Medical Research Institute
    Cambridge, Massachusetts, United States

  • AA

    Aparna B. Anderson, PhD

    Bill and Melinda Gates Medical Research Institute
    Glastonbury, Connecticut, United States

  • DT

    Dale Taylor, MD

    Medical Director
    PPD, part of Thermo Fisher Scientific
    Orlando, Florida, United States

  • JW

    Joleen T. White, PhD

    Head of Bioassay Development
    Bill & Melinda Gates Medical Research Institute
    Cambridge, Massachusetts, United States

    • Presenting Author(s)

  • Luisa M. Stamm, MD, PhD

    Clinical Development Leader
    Bill & Melinda Gates Medical Research Institute
    Cambridge, Massachusetts, United States

    • Co-Author(s)

  • MD

    Michael W. Dunne, MD

    Bill & Melinda Gates Medical Research Institute
    Cambridge, Massachusetts, United States